ELEKTA ESTABLISH NEW SUBSIDIARY IN AUSTRALIA

Thu, Jun 24, 2004 10:00 CET

ELEKTA ESTABLISH NEW SUBSIDIARY IN AUSTRALIA
PRESS RELEASE
Stockholm, June 24, 2004
ELEKTA ESTABLISH NEW SUBSIDIARY IN AUSTRALIA
Elekta, a world-leading supplier of advanced and innovative radiation oncology and neurosurgery solutions, today on Thursday, June 24, 2004 started up operations of its new subsidiary organization in Australia, Elekta Pty. Ltd.
"As a result of our long-term commitment to the whole Asia-Pacific region, Elekta has seized the opportunity to fully realize our potential in the growing markets for both radiation therapy and neurosurgery systems in Australia and New Zealand. Operating directly in the region will ensure we are best placed to achieve that and to serve the clinical needs of our customers", says Tomas Puusepp, Elekta's Executive Vice President - Sales, Marketing & Service
Elekta has been supplying clinical solutions to Australia for more than 20 years and has a strong customer base in the country with numerous installations in Sydney, Melbourne, Perth, Brisbane and Townsville. Recently Elekta has won very significant orders in both Sydney and Perth. The establishment of a new subsidiary involves the transfer of staff and contracts, made in cooperation with Elekta's previous distributor.
The new Elekta office will be located in Sydney, New South Wales, with sales and service personnel operating directly from strategic locations around the country.
"We see a growing market in Australia and New Zealand and with a strong new Elekta team we will be well equipped to serve the community's needs for more efficient and less invasive treatment methods by supplying state-of-the-art technology and clinical solutions to both existing and potential customers", says Brendan Vahey, Director of Elekta Pty. Ltd., head of Elekta's operations in Australia.
For further information, please contact:
International: Peter Ejemyr, Group VP Corporate Communications, Elekta AB (publ),
Phone: +46 733 611 000, e-mail: peter.ejemyr@elekta.com
United States: Lars Jonsteg, VP Investor Relations North America, Elekta, USA
Phone: +46 708 78 37 35, e-mail: lars.jonsteg@elekta.com
Elekta is a world-leading supplier of advanced and innovative radiation oncology and neurosurgery solutions and services for precise treatment of cancer and brain disorders. Elekta's solutions are clinically effective, cost efficient and gentle to the patient.
For additional information about Elekta, please visit www.elekta.com
------------------------------------------------------------
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://www.waymaker.net/bitonline/2004/06/24/20040623BIT22380/wkr0010.pdf PDF Version

About Us

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,700 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com